PIK Care & Counsel IV Listserve Archive

DateSubject
Oct. 05, 2006 Interferon-related headaches RESPONSES (10/5/06)
Sep. 29, 2006Interferon-related headaches
Sep. 14, 2006Gout Meds
Sep. 07, 2006Hepatitis B Case - RESPONSES (9/7/06)
Aug. 29, 2006Hepatitis B Case
Aug. 02, 2006Treatment Duration - RESPONSES (8/02/06)
Jul. 28, 2006Treatment Duration
Jun. 30, 2006Genotypes 2 and 3 Do Not Need Weight-Based Dosing or 48-Week Treatment
Jun. 29, 2006To Treat or Not to Treat? RESPONSES (6/29/06)
Jun. 28, 2006Patient Support Program Improves Adherence
Jun. 28, 2006To Treat or Not to Treat (Responses 6/28/06)
Jun. 27, 2006To Treat or Not to Treat? RESPONSES (6/27/06)
Jun. 27, 2006 To Treat or Not to Treat?
Jun. 23, 2006More Support for Maintenance Therapy
Jun. 23, 2006Length of Treatment After Obtaining Negative Viral Load on Treatment - RESPONSES 6/23/06
Jun. 20, 2006Lok Index Not as Good as FibroScan/FibroTest
Jun. 16, 2006Length of Treatment After Obtaining Negative Viral Load on Treatment - RESPONSE 6/16/06
Jun. 16, 2006Shrinking Tumors to Qualify for Transplant? RESPONSE 6/16/06
Jun. 16, 2006Normal ALT Does Not Limit Response to Anti-HCV Treatment
Jun. 13, 2006Rapid Virologic Response Is a Good Indicator of SVR
Jun. 13, 2006Shrinking Tumors to Qualify for Transplant?
Jun. 09, 2006Length of Treatment After Obtaining Negative Viral Load on Treatment
Jun. 09, 2006Heavier HCV Patients Have Worse Prognostic Factors and Outcomes
Jun. 08, 2006Blacks with Genotype 1 Have Lower SVR Rates Than non-Blacks
May. 31, 2006Thalidomide for IFN/RBV Nonresponders
May. 25, 2006Liver Biopsy as Gold Standard?
May. 19, 2006Week-12 Ribavirin Level Not Predictive of EVR or Severe Anemia in Combination Therapy
May. 09, 2006Hep C and renal failure MORE RESPONSES 5/9/06
May. 09, 2006TB MORE RESPONSES 5/9/06
May. 04, 2006Hep C and renal failure MORE RESPONSES 5/4/06
May. 04, 2006TB RESPONSES 5/4/06
May. 03, 2006HCV Diagnosis: A Major Stressful Life Event
May. 02, 2006Hep C and renal failure RESPONSES 5/2/06
May. 02, 2006Insulin Resistance
May. 02, 2006 TB
Apr. 25, 2006Interferon Plus Ribavirin Associated with Improved Quality of Life in Patients with Normal ALT HCV levels
Apr. 28, 2006Hep C and renal failure
Apr. 21, 2006Hepatic Steatosis Predicts Poor Response to Interferon/Ribavirin Therapy
Apr. 18, 2006Simple Saliva Test for HCV May Hold Great Promise
Apr. 11, 2006Hepatitis B Satellite Symposium at DDW 2006
Apr. 07, 2006HTLV and Hepatitis C
Apr. 04, 2006Features of HCV in Hispanics
Mar. 30, 2006Unexpected Spontaneous HCV RNA Clearance After Chronic Infection
Mar. 27, 2006Myoclonus Jerks on Treatment RESPONSES 3/27/06
Mar. 24, 2006Protease Inhibitor Triple Therapy Achieves 100% in Genotype 1
Mar. 24, 2006Monocytosis
Mar. 24, 2006Myoclonus Jerks on Treatment RESPONSES 3/24/06
Mar. 23, 2006Myoclonus Jerks on Treatment
Mar. 21, 2006Lymphadenopathy and Interferon Alfacon-1
Mar. 21, 2006Hemolytic Anemia MORE RESPONSES 3/21/06
Mar. 20, 2006Hemolytic Anemia RESPONSES 3/20/06
Mar. 17, 2006Early Registration for 2006 DDW Ends April 14
Mar. 16, 2006Pulmonary Hypertension MORE RESPONSES 3/16/06
Mar. 16, 2006Hemolytic Anemia
Mar. 16, 2006Posttreatment Hair Loss MORE RESPONSES 3/16/06
Mar. 15, 2006Risk Factor for Depression During Interferon Treatment
Mar. 15, 2006Polyuria
Mar. 15, 2006Posttreatment Hair Loss RESPONSES 3/15/06
Mar. 13, 2006Posttreatment Hair Loss RESPONSES 3/13/06
Mar. 10, 2006Pulmonary Hypertension RESPONSES 3/10/06
Mar. 10, 2006Screening for HCV: Case Study MORE RESPONSES 3/10/06
Mar. 10, 2006Posttreatment Hair Loss
Mar. 08, 2006Pulmonary Hypertension
Mar. 08, 2006Oprelvekin in Compensated Cirrhotics RESPONSES 3/8/06
Mar. 06, 2006Screening for HCV: Case Study MORE RESPONSES 3/6/06
Mar. 03, 2006Racial Disparities Seen in Liver Transplantation for HCC
Mar. 03, 2006Screening for HCV: Case Study MORE RESPONSES 3/3/06
Mar. 02, 2006Oprelvekin in Compensated Cirrhotics
Mar. 02, 2006Screening for HCV: Case Study RESPONSES 3/2/06
Mar. 01, 2006Please welcome our moderator for the month of March 2006
Feb. 28, 2006Screening for HCV: Case Study
Feb. 24, 2006Older HCV Patients Less Likely to Tolerate Combination Therapy
Feb. 24, 2006Treating Patient with Idiopathic Thrombocytopenia (RESPONSES 2/24/06)
Feb. 21, 2006Treating Patient with Idiopathic Thrombocytopenia (RESPONSES 2/21/06)
Feb. 21, 2006HCV RNA Rebounds Quickly Following Liver Transplants
Feb. 21, 2006HCV RNA Rebounds Quickly Following Liver Transplants
Feb. 20, 2006Treating Patient with Idiopathic Thrombocytopenia (RESPONSES TO 2/20/06)
Feb. 17, 2006Treating Patient with Idiopathic Thrombocytopenia
Feb. 14, 2006HCV Fibrosure Testing (RESPONSES 2/13/06)
Feb. 14, 2006Undetected Hepatitis C Levels and Being “Contagious” (RESPONSES 2/14/06)
Feb. 14, 2006Effect of Viral Irradication on Polyarthralgias (RESPONSES 2/14/06)
Feb. 13, 2006Thymalfasin Ineffective in HCV Nonresponders
Feb. 13, 2006Lysine--Risks or Benefits for Hepatitis C Patients (RESPONSES 2/13/06)
Feb. 09, 2006Effect of Viral Irradication on Polyarthralgias (RESPONSES 2/9/06)
Feb. 09, 2006Undetected Hepatitis C Levels and Being “Contagious” (RESPONSES 2/9/06)
Feb. 09, 2006HCV Fibrosure Testing
Feb. 08, 2006Undetected Hepatitis C Levels and Being “Contagious”
Feb. 08, 2006Effect of Viral Irradication on Polyarthralgias
Feb. 08, 2006HCV and Elective Cesarean Section
Feb. 08, 2006HCV and Elective Cesarean Section
Feb. 07, 2006Lysine--Risks or Benefits for Hepatitis C Patients
Feb. 02, 2006Cyclosporine and Better Long-term Viral Response in HCV Patients
Jan. 30, 2006Hepatitis Resource for Patients
Jan. 27, 2006HCV RNA Level Predicts ESLD
Jan. 25, 2006Investigational HCV Drug Gets Fast-Track Designation from FDA
Jan. 23, 2006Excluding HCV Patients with co-Morbidities from Treatment
Jan. 19, 2006Obesity and HCV-Related HCC
Jan. 19, 2006PEG IFN/RBV Nonresponders and Consensus Interferon (Responses to 1/19/06)
Jan. 19, 2006Interferon Therapy for Schizophrenics and Substance Abusers with HCV (RESPONSES TO 1/19/06)
Jan. 17, 2006PEG IFN/RBV Nonresponders and Consensus Interferon
Jan. 17, 2006Interferon Therapy for Schizophrenics and Substance Abusers with HCV
Jan. 10, 2006Healthcare Costs for HCV on the Rise
Jan. 09, 2006Elevated AFP Indicates Poor Prognosis in Chronic Hepatitis C—With or Without HCC (RESPONSES 1/9/06)
Jan. 06, 2006Largest HCV Trial Indicates Weight-Based RBV Improves SVR
Jan. 05, 2006Weight-Based Peginterferon alfa-2b/Ribavirin Safe for Advanced Disease
Dec. 29, 2005Heart patient seeking treatment (RESPONSES 12/29/05)
Dec. 29, 2005Elevated AFP Indicates Poor Prognosis in Chronic Hepatitis C—With or Without HCC
Dec. 21, 2005Efficacy of Increased Doses of PEG IFN and Ribavirin in Nonresponders
Dec. 21, 2005Heart patient seeking treatment (RESPONSES 12/21/05)
Dec. 21, 2005Heart patient seeking treatment
Dec. 20, 2005HCV RNA levels and length of therapy (RESPONSES 12/20/05)
Dec. 20, 2005Children with HCV Respond Well to Interferon/Ribavirin Combination Therapy
Dec. 19, 2005HCV RNA levels and length of therapy (RESPONSES 12/19/05)
Dec. 19, 2005HCV Transmission and Occupational Exposure
Dec. 16, 2005Weight Los and Peginterferon/Ribavirin Combination Therapy
Dec. 16, 2005HCV RNA levels and length of therapy
Dec. 15, 2005HCV Increases Toxicity-Related HAART Discontinuations
Dec. 12, 2005Report Shows UK Failing to Combat HCV
Dec. 07, 2005Hepatic Stellate Cell Activation After Liver Transplant and Risk of Advanced Fibrosis
Dec. 05, 2005American Liver Foundation Criticizes “Bewitched” Joke About Hepatitis C (RESPONSES 12/05/05)
Dec. 01, 2005Digestive Endoscopy and Transmission of Hepatitis C
Dec. 01, 2005Hepatitis C Clinicians in Albany, NY
Dec. 01, 2005Hepatitis C and Pneumococcal Vaccine (RESPONSES 12/1/05)
Dec. 01, 2005Please welcome our moderator for the month of December 2005
Nov. 28, 2005American Liver Foundation Criticizes “Bewitched” Joke About Hepatitis C
Nov. 22, 2005HCV Transmission in Outpatient Clinics
Oct. 24, 2005Acute Hepatitis C in a Young Pregnant Female (RESPONSES 10/24/05)
Oct. 24, 2005Treating fatigue in hepatitis C patients (RESPONSES 10/24/05)
Oct. 17, 2005Treating fatigue in hepatitis C patients
Oct. 17, 2005Study Shows Hepatitis C Remains Undertreated
Oct. 14, 2005Acute Hepatitis C in a Young Pregnant Female (RESPONSES 10/14/05)
Oct. 14, 2005Care & Counsel IV  Regional Meetings
Oct. 11, 2005Hepatitis C Virus Replicated in Laboratory
Oct. 11, 2005Acute Hepatitis C in a Young Pregnant Female
Oct. 07, 2005Prevention of Bone Loss Following Liver Transplant.
Sep. 27, 2005NIH to Study Silymarin in Chronic Liver Disease
Sep. 23, 2005Interferon May Reduce Long-Term Risk of HCC
Sep. 23, 2004Message from Ruth Corbett, BSN, MSN, ARNP (MORE RESPONSES 9/23/05)
Sep. 22, 2005Nitric Oxide Predicts Response to anti-HCV Interferon Therapy
Sep. 22, 2005Lipid Profile May Predict HCV Treatment Outcome. RESPONSES 9/22/05
Sep. 20, 2005HBV Education
Sep. 20, 200512-Week PEG IFN/RBV for HCV Genotype 2/3
Sep. 19, 2005Treatment in Decompensated Cirrhotics RESPONSES 9/19/05
Sep. 16, 2005Insulin Resistance Questions (RESPONSES 9/16/05)
Sep. 16, 2005Treatment in Decompensated Cirrhotics RESPONSES 9/16/05
Sep. 16, 2005Message from Ruth Corbett, BSN, MSN, ARNP (MORE RESPONSES TO 9/16/05)
Sep. 16, 2005Colonoscopy Before Treatment for HCV Patients Older than 50 years
Sep. 15, 2005All-Trans-Retinoic Acid Aids Retreatment of HCV Nonresponders
Sep. 15, 2005Treatment in Decompensated Cirrhotics
Sep. 15, 2005Insulin Resistance Questions (RESPONSES 9/15/05)
Sep. 13, 2005 Hyperpigmentation (RESPONSES TO 9/13/05)
Sep. 13, 2005Insulin Resistance Questions
Sep. 12, 2005Alcohol Consumption Associated with High Viral Load in HCV  UPDATED LINK
Sep. 12, 2005Lipid Profile May Predict HCV Treatment Outcome.
Sep. 08, 2005Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Sep. 07, 2005Genotype 2 and 3 African Americans
Sep. 02, 2005Alcohol Consumption Associated with High Viral Load in HCV
Sep. 02, 2005Hyperpigmentation (RESPONSES TO 9/2/05)
Sep. 02, 2005Interferon reduces long-term risk of HCC in HCV patients - NEW LINK
Sep. 01, 2005Pleasse welcome our moderator for the month of September 2005
Aug. 31, 2005Interferon reduces long-term risk of HCC in HCV patients
Aug. 31, 2005Prevention of Interferon-Induced Depression in Treatment of HCV (RESPONSES TO 8/31/05)
Aug. 31, 2005Hyperpigmentation (RESPONSES TO 8/31/05)
Aug. 29, 2005Hyperpigmentation
Aug. 22, 2005HCV Interferon Treatment Reduces Liver-Related Mortality
Aug. 24, 2005Growth Factors Increase SVR in HCV Treatment
Aug. 25, 2005Message from Ruth Corbett, BSN, MSN, ARNP (MORE RESPONSES TO 8/25/05)
Aug. 19, 2005Message from Ruth Corbett, BSN, MSN, ARNP (MORE RESPONSES TO 8/19/05)
Aug. 19, 2005Daily Cannabis Use is Risk Factor for Fibrosis in HCV
Aug. 18, 2005Interferon-based Treatment of Decompensated HCV Cirrhosis (RESPONSES TO 8/18/05)
Aug. 18, 2005Message from Ruth Corbett, BSN, MSN, ARNP (RESPONSES TO 8/18/05)
Aug. 17, 2005Risk of Dysthyroidism in Interferon Treatment
Aug. 16, 2005Cutaneous Vasculitis (RESPONSES TO 8/16/05)
Aug. 16, 2005Messge from Ruth Corbett, BSN, MSN, ARNP (MORE RESPONSES 8/16/05)
Aug. 15, 2005Message from Ruth Corbett, BSN, MSN, ARNP (RESPONSES TO 8/15/05)
Aug. 15, 2005New-Onset Diabetes After Liver Transplant
Aug. 12, 2005Message from Ruth Corbett, BSN, MSN, ARNP (RESPONSES TO 8/12/05)
Aug. 12, 2005Cutaneous Vasculitis (RESPONSES TO 8/12/05)
Aug. 12, 2005Please welcome our moderator for the month of August 2005
Aug. 11, 2005Interferon-based Treatment of Decompensated HCV Cirrhosis
Aug. 10, 2005Cutaneous Vasculitis (RESPONSES TO 8/10/05)
Aug. 10, 2005Message from Ruth Corbertt, BSN, MSN, ARNP
Jul. 18, 2005Care & Counsel IV Listserve
Aug. 02, 2005New Initiative Against Hepatitis C Launched by the NACHC
Jul. 28, 2005Cutaneous Vasculitis
Jul. 28, 2005What Defines Cure for HCV?
Jul. 28, 2005 Testing Spouse for HCV (RESPONSES TO 7/28/05)
Jul. 28, 2005Congratulations
Jul. 08, 2005Testing Spouse for HCV (RESPONSES TO 7/08/05)
Jun. 28, 2005Low-iron diet and HCV (RESPONSES TO 6/28/05)
Jun. 24, 2005Antifibrogenic Effect of Estrogen
Jun. 22, 2005 Low-iron diet and HCV
Jun. 21, 2005Protease Inhibitor Looks Promising
Jun. 17, 2005SVR for 48 versus 24 weeks (RESPONSES TO 6/17/05)
Jun. 15, 2005HCV and Psoriatic Arthritis
Jun. 10, 2005SVR for 48 versus 24 weeks
Jun. 10, 2005Testing Spouse for HCV
Jun. 08, 2005 Steatosis in HIV/HCV Coinfected Patients
Jun. 02, 2005ESRD Patients Still Have High Prevalence of HCV
May. 24, 2005Genotype 6 (RESPONSES TO 5/24/05)
May. 19, 2005Genotype 6 (RESPONSES TO 5/19/05)
May. 18, 2005Genotype 6 (RESPONSES TO 5/18/05)
May. 11, 2005Genotype 6 (RESPONSES TO 5/11/05)
May. 10, 2005Etanercept Use in Patient with Liver Disease? (RESPONSES TO 5/10/05)
May. 05, 2005Genotype 6
May. 05, 2005Etanercept Use in Patient with Liver Disease?
May. 03, 2005Restless Legs Syndrome Due to Interferon-alfa (RESPONSES TO 5/03/05)
May. 02, 2005Please welcome our moderator for the month of May 2005
Apr. 29, 2005HCV Persists Long After Viral Clearance FOLLOW-UP TO 4/28/05
Apr. 29, 2005Restless Legs Syndrome Due to Interferon-alfa (RESPONSES TO 4/28/05)
Apr. 28, 2005Correlation of Gallbladder Disease and HCV
Apr. 27, 2005Restless Legs Syndrome Due to Interferon-alfa (RESPONSES TO 4/27/05)
Apr. 27, 2005HCV Persists Long After Viral Clearance FOLLOW-UP TO 4/26/05
Apr. 25, 2005HCV Persists Long After Viral Clearance FOLLOW-UP TO 4/25/05
Apr. 25, 2005Risk of Liver Cancer After SVR
Apr. 25, 2005Restless Legs Syndrome Due to Interferon-alfa (RESPONSES TO 4/25/05)
Apr. 25, 2005Hyperthyroidism on Therapy (RESPONSES TO 4/25/05)
Apr. 19, 2005Model Predicts Fibrosis in transplant Recipients
Apr. 19, 2005Hyperthyroidism on Therapy
Apr. 14, 2005Restless Legs Syndrome Due to Interferon-alfa
Apr. 15, 2005Pharmacokinetics of Methadone Not Altered by Peginterferon alfa-2a. FOLLOW-UP 4/14/05
Apr. 13, 2005Pharmacokinetics of Methadone Not Altered by Peginterferon alfa-2a. FOLLOW-UP 4/13/05
Apr. 13, 2005Role of Ribavirin in Peginterferon Anti-HCV Treatment FOLLOW-UP 4/13/05
Apr. 11, 2005HCV Persists Long After Viral 'Clearance' FOLLOW-UP TO 4/11/05
Apr. 08, 2005Role of Ribavirin in Peginterferon Anti-HCV Treatment
Apr. 05, 2005Pharmacokinetics of Methadone Not Altered by Peginterferon alfa-2a.
Apr. 04, 2005Acute Hepatitis C? RESPONSES TO 4/4/05
Apr. 04, 2005Higher Serum Iron Levels Linked to HCV Infection. (RESPONSES TO DATE 4/4/05)
Apr. 01, 2005DDW 2005: Last Chance for Early Registration
Apr. 01, 2005Higher Serum Iron Levels Linked to HCV Infection. (RESPONSES TO 4/1/05)
Apr. 01, 2005Please welcome our moderator for the month of April, 2005
Mar. 30, 2005Higher Serum Iron Levels Linked to HCV Infection
Mar. 28, 2005Transmission of HCV Rare in Men Having Sex with Men. Sexual
Mar. 25, 2005Acute Hepatitis C? RESPONSES TO 3/25/05
Mar. 25, 2005Education of Homeless Injecting Drug Users
Mar. 25, 2005Acute Hepatitis C? RESPONSES TO 3/25/05
Mar. 25, 2005Education of Homeless Injecting Drug Users
Mar. 25, 2005Acute Hepatitis C? RESPONSES TO 3/25/05
Mar. 23, 2005HCV Persists Long After Viral 'Clearance'
Mar. 23, 2005Acute Hepatitis C?
Mar. 22, 2005ALT Levels Correlate with HCC After Interferon
Mar. 18, 2005Depression Lowers Response, Independent of Adherence
Mar. 17, 2005Hepatitis B and C Added to Government¹s Report on Carcinogens
Mar. 17, 2005Ribavirin in Patients with Kidney Disease, Cryoglobulinemia RESPONSES TO 3/17/05
Mar. 16, 2005Antiviral Treatment in Patients with Autoantibodies
Mar. 16, 2005Combination Test for Genotype and Viral Load FOLLOW-UP
Mar. 15, 2005FDA Approves First HCV Treatment for HIV Patients
Mar. 15, 2005Ribavirin in Patients with Kidney Disease, Cryoglobulinemia
Mar. 11, 2005Model of End-stage Liver Disease in Severe Viral Hepatitis
Mar. 10, 2005A Thank-you to C & C III RESPONSES TO 3/10/05
Mar. 08, 2005High, Individualized Dose of Ribavirin with Peginterferon
Mar. 08, 2005A Thank-you to C & C III RESPONSES TO 3/8/05
Mar. 07, 2005Coffee and Caffeine Intake Reduces Risk of Elevated ALT
Mar. 04, 2005Crystal Methamphetamine Use Increases HCV Prevalence
Mar. 03, 2005A Thank-you to C & C III RESPONSES TO 3/3/05
Mar. 02, 2005A Thank-you to C & C III
Mar. 01, 2005Liver Regeneration and Increased Risk for HCV Recurrence
Feb. 23, 2005Combination Test for Genotype and Viral Load
Feb. 23, 2005Treating Patients with Seizure Disorder (RESPONSES TO 2/23/05)
Feb. 22, 200514-Week PEG IFN/RBV for Genotype 2/3 -- RESPONSES TO 2/22/05
Feb. 17, 200514-Week PEG IFN/RBV for Genotype 2/3 RESPONSES TO 2/17/05
Feb. 15, 200514-Week PEG IFN/RBV for Genotype 2/3
Feb. 14, 2005Are "Normal" ALT Values Really Normal? (RESPONSES TO 2/14/05)
Feb. 14, 2005Posttreatment Fatigue (RESPONSES TO 2/14/05)
Feb. 11, 2005Juzen-Taiho-To and Ribavirin-Induced Anemia
Feb. 08, 2005Are "Normal" ALT Values Really Normal?
Feb. 08, 2005Posttreatment Fatigue (RESPONSES TO 2/7/05)
Feb. 04, 2005Posttreatment Fatigue
Feb. 03, 2005Treating HCV/HIV-Coinfected Patients
Feb. 01, 2005Please Welcome Our Moderator for the Month of February 2005
Feb. 01, 2005Dental Caries While on HCV Treatment (RESPONSES TO 2/1/05)
Jan. 31, 2005Hepatitis C Clinical Trials
Jan. 27, 2005Rising Alkaline Phosphatase (RESPONSES TO 1/27/05)
Jan. 27, 2005Routine Screening for Interferon-Induced Retinopathy (RESPONSES TO 1/27/05)
Jan. 26, 2005Improved Survival in IFN-Treated Older Patients
Jan. 25, 2005Rising Alkaline Phosphatase
Jan. 25, 2005Dental Caries While on HCV Treatment (RESPONSES TO 1/25/05)
Jan. 24, 2005Evaluation of Milk Thistle (Silymarin)
Jan. 21, 2005Routine Screening for Interferon-Induced Retinopathy
Jan. 20, 2005Treatment of Patients with Seizure Disorder (RESPONSES TO 1/20/05)
Jan. 20, 2005Dental Caries While on HCV Treatment (RESPONSES TO 1/20/05)
Jan. 20, 2005Tinnitus (RESPONSES TO 1/20/05)
Jan. 20, 2005Epoetin alfa and Health-Related Quality of Life
Jan. 19, 2005Dental Caries While on HCV Treatment (RESPONSES TO 1/19/05)
Jan. 18, 2005Dental Caries While on HCV Treatment
Jan. 18, 2005DDW 2005
Jan. 17, 2005Whole-Blood Versus Serum/Plasma Testing for Detection of HCV RNA
Jan. 14, 2005Race and HCV
Jan. 13, 2005Genotype 3 (RESPONSES TO 1/13/05)
Jan. 13, 2005Tinnitus (RESPONSES TO 1/13/05)
Jan. 12, 2005Genotype 3
Jan. 12, 2005Tinnitus (RESPONSES to 1/12/05)
Jan. 12, 2005HCV and Gallbladder Disease
Jan. 11, 2005Tinnitus
Jan. 11, 2005Facial and Postauricular Neuralgia
Jan. 11, 2005Treatment of Patients with Seizure Disorder (RESPONSES TO 1/11/05)
Jan. 03, 2005Treatment of Patients with Seizure Disorder
Dec. 30, 2004Please welcome our moderator for the month of January 2005
Dec. 22, 2004Season's Greetings
Dec. 22, 2004Progression of Chronic HCV to Cirrhosis (RESPONSES TO 12/22/04)
Dec. 21, 2004Progression of Chronic HCV to Cirrhosis (RESPONSES TO 12/20/04)
Dec. 15, 2004Causes of fatigue in HCV (RESPONSES TO 12/15/04)
Dec. 10, 2004Causes of fatigue in HCV
Dec. 09, 2004Progression of Chronic HCV to Cirrhosis
Dec. 03, 2004VEGF Levels Predict Ocular Side Effects of Interferon
Dec. 02, 2004Peginterferon alfa-2a vs alfa-2b in Reducing HCV Viral Load
Nov. 30, 2004Standard Screening for Substance Use Disorders in Patients withHCV
Nov. 30, 2004Helped for Dry, Chapped Skin (RESPONSES TO 11/30/04)
Nov. 24, 2004Women, Social Stigma, and HCV (MORE RESPONSES - 11/24/04)
Nov. 24, 2004Helped for Dry, Chapped Skin
Nov. 22, 2004Women, Social Stigma, and HCV (RESPONSES TO 11/22/04)
Nov. 19, 2004Memory and Concentration Problems in Hepatitis C Treatment (MORE RESPONSES 11/19/04)
Nov. 15, 2004Memory and Concentration Problems in Hepatitis C Treatment (MORE RESPONSES 11/15/04 PM)
Nov. 15, 2004Memory and Concentration Problems in Hepatitis C Treatment (RESPONSES TO 11/15/04)
Nov. 15, 2004Memory and Concentration Problems in Hepatitis C Treatment
Nov. 12, 2004Women, Social Stigma, and HCV
Nov. 10, 2004Predicting Ribavirin-Induced Anemia (RESPONSES TO 11/10/04)
Nov. 10, 2004Injection Site Question
Nov. 10, 2004Hepatitis C and non-Hodgkin's Lymphoma
Nov. 08, 2004CNS and HCV
Nov. 05, 2004Nonresponders to PEG IFN/RBV
Nov. 02, 2004Predicting Ribavirin-Induced Anemia
Nov. 02, 2004Q: Genotype (RESPONSES TO 11/02/04)
Nov. 01, 2004Please welcome our moderator for November and December 2004
Oct. 29, 2004Genotype
Oct. 29, 2004Supportive Nursing and Interferon-Induced Mood Disorders
Oct. 27, 2004Renal Transplant Patients
Oct. 26, 2004Anti HCV Therapy and Black Cohosh
Oct. 25, 2004Risk factors for HCC after sustained response to interferon
Oct. 22, 2004Link Accessibility - Risk Factors for HCC After Sustained Response to Interferon
Oct. 22, 2004Risk Factors for HCC After Sustained Response to Interferon
Oct. 20, 2004Vitamin K2 and HCC in women with viral cirrhosis
Oct. 18, 2004Hepatitis single-topic conference
Oct. 15, 2004Ethnicity and chronic hepatitis C
Oct. 07, 2004Dronabinol and PEG IFN/RBV side effects (RESPONSES TO DATE 10/7/04)
Oct. 07, 2004Diagnostic value of FibroTest and ActiTest (RESPONSES TO 10/7/04)
Oct. 07, 2004Dronabinol and PEG IFN/RBV side effects
Oct. 07, 2004ETR Follow-up of HCV Patients (RESPONSES TO 10/07/04)
Oct. 07, 2004Headaches (MORE RESPONSES 10/7/04)
Oct. 05, 2004Headaches (RESPONSES TO DATE 10/5/04)
Oct. 05, 2004Diagnostic value of FibroTest and ActiTest
Oct. 05, 2004ETR Follow-up of HCV Patients
Oct. 04, 2004Headaches
Oct. 04, 2004CDC Hep C fact sheet updated (RESPONSES TO DATE 10/04/04)
Oct. 04, 2004Smoking limits response to interferon (RESPONSES TO DATE 10/4)
Oct. 01, 2004Smoking limits response to interferon
Oct. 01, 2004Welcoming October's Moderator
Sep. 30, 2004CDC Hep C fact sheet updated
Sep. 28, 2004New book on hepatitis and liver disease
Sep. 27, 2004Living-donor vs deceased-donor liver transplants
Sep. 20, 2004American College of Gastroenterology Meeting 10/29-11/03/04
Sep. 17, 2004HCV and Itchy Rash (RESPONSES TO 9/15)
Sep. 17, 2004Liver Patients and Alternative Medicine
Sep. 15, 2004Treating Patients on Methadone Therapy
Sep. 15, 2004HCV and Itchy Rash
Sep. 13, 2004Retinopathy - MORE RESPONSES (9/10/04)
Sep. 13, 2004Effect of BMI on treatment response
Sep. 10, 2004Upcoming Symposiums
Sep. 10, 2004Retinopathy - MORE RESPONSES (9/9/04)
Sep. 09, 2004Retinopathy MORE RESPONSES (9/9/04)
Sep. 08, 2004Retinopathy RESPONSES TO 9/8/04
Sep. 08, 2004AASLD Annual Meeting 10/29-11/02/04
Sep. 08, 200447-year-old female with HCV-1 (MORE RESPONSES 9/7/04)
Sep. 07, 2004Retinopathy
Sep. 07, 2004(Sexual Transmission of HCV MORE RESPONSES (9/7/04)
Sep. 03, 2004Sexual Transmission of HCV
Sep. 03, 2004Hep C Patients Curing Themselves? (RESPONSES 9/3/04)
Sep. 03, 200447-year-old female with HCV-1 (RESPONSES TO 9/3/04)
Sep. 01, 2004Mouth Sores (MORE RESPONSES 8/31/04)
Sep. 01, 200447-year-old female with HCV-1 (MORE RESPONSES 8/31/04)
Sep. 01, 2004HCV and Diabetes
Aug. 30, 200447-year-old female with HCV-1 (MORE RESPONSES 8/30/04)
Aug. 30, 2004Hep C Patients Curing Themselves?
Aug. 26, 200447-year-old female with HCV-1 (RESPONSES TO 8/25/04)
Aug. 24, 200447-year-old female with HCV-1
Aug. 24, 2004Mouth Sores - (MORE RESPONSES 8/24/04)
Aug. 19, 2004Subject: Mouth Sores (RESPONSES TO 8/18/04)
Aug. 17, 2004Q: Mouth Sores
Aug. 16, 2004Sunscreen reaction
Aug. 13, 2004Special Announcement